Effect of epigallocatechin-3-gallate (EGCG) on cognitive functioning and the expression of APP and BDNF in the hippocampus of rats with streptozotocin -induced Alzheimer-like disease.

Biochem Biophys Rep · 2025 · PMC11841203 · PMID 39980585

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a slight trendno p-value reported

In our study, high doses showed a slight trend toward the improvement of memory and molecular changes in AD rats, but low dose (25 mg/kg) only showed significant effectiveness.

also in 4,078 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.